Skip to main content
Erschienen in: Annals of Surgical Oncology 7/2007

01.07.2007 | Gastrointestinal Oncology

Patients with Locally Advanced Esophageal Carcinoma Nonresponder to Radiochemotherapy: Who Will Benefit From Surgery?

verfasst von: Guillaume Piessen, Nicolas Briez, Jean-Pierre Triboulet, Christophe Mariette

Erschienen in: Annals of Surgical Oncology | Ausgabe 7/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

In patients who are nonresponders to primary radiochemotherapy (RCT), prognosis is poor, leading mostly to palliation. Salvage surgery may have a survival benefit otherwise complete. Our aim was to identify predictors of R0 resection in these patients.

Methods

In 98 nonresponders with locally advanced infracarinal tumors, curative salvage surgery was attempted. Resection was R0 in 62.2% and incomplete in 37.8% of cases. Univariate and multivariate analyses included pre-RCT and post-RCT variables collected prospectively.

Results

Overall survival was higher in the R0 resection group (18.4 vs 8.6 months, P < .001). Independent predictors of R0 resection were tumor height ≤ 5 cm on barium swallow (P = .045) and aortic contact ≤ 90° on computed tomography (P = .039) evaluated after RCT. Three groups of patients were constructed: 1, tumor height ≤ 5 cm with aortic contact ≤ 90° (n = 43); 2, tumor height between 6 and 10 cm with aortic contact ≤ 90° (n = 32); and 3, aortic contact > 90°, irrespective of tumor height (n = 23). Rates of R0 resection were 81%, 53%, and 39%, respectively (P = .001).

Conclusion

Salvage esophagectomy should be systematically attempted in nonresponders with tumor height ≤ 5 cm on barium swallow and aortic contact ≤ 90° on computed tomography and discussed case by case for other patients.
Literatur
1.
Zurück zum Zitat Brenner B, Ilson DH, Minsky BD. Treatment of localized esophageal cancer. Semin Oncol 2004; 31:554–65PubMedCrossRef Brenner B, Ilson DH, Minsky BD. Treatment of localized esophageal cancer. Semin Oncol 2004; 31:554–65PubMedCrossRef
2.
Zurück zum Zitat Mariette C, Triboulet JP. Is preoperative chemoradiation effective in treatment of oesophageal carcinoma? Lancet Oncol 2005; 6:635–7PubMedCrossRef Mariette C, Triboulet JP. Is preoperative chemoradiation effective in treatment of oesophageal carcinoma? Lancet Oncol 2005; 6:635–7PubMedCrossRef
3.
Zurück zum Zitat Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23:2310–7PubMedCrossRef Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23:2310–7PubMedCrossRef
4.
Zurück zum Zitat Bedenne L, Michel P, Bouché O, Milan C, Mariette C, Conroy T, et al. Chemo-radiation followed by surgery compared to chemo-radiation alone in locally advanced operable oesophageal cancer: a randomised multicentric phase III trial (FFCD 9102). J Clin Oncol. 2007, in press Bedenne L, Michel P, Bouché O, Milan C, Mariette C, Conroy T, et al. Chemo-radiation followed by surgery compared to chemo-radiation alone in locally advanced operable oesophageal cancer: a randomised multicentric phase III trial (FFCD 9102). J Clin Oncol. 2007, in press
5.
Zurück zum Zitat Jeremic B, Shibamoto Y, Acimovic L, Matovic Z, Milicic B, Milisavljevic S, et al. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study. Int J Radiat Oncol Biol Phys 1998; 40:1061–6PubMedCrossRef Jeremic B, Shibamoto Y, Acimovic L, Matovic Z, Milicic B, Milisavljevic S, et al. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study. Int J Radiat Oncol Biol Phys 1998; 40:1061–6PubMedCrossRef
6.
Zurück zum Zitat Mariette C, Taillier G, Van Seuningen I, Triboulet JP. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg 2004; 78:1177–83PubMedCrossRef Mariette C, Taillier G, Van Seuningen I, Triboulet JP. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg 2004; 78:1177–83PubMedCrossRef
7.
Zurück zum Zitat Di Fiore F, Lecleire S, Rigal O, Galais MP, Ben Soussan E, David I, et al. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12:4185–90PubMed Di Fiore F, Lecleire S, Rigal O, Galais MP, Ben Soussan E, David I, et al. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12:4185–90PubMed
8.
Zurück zum Zitat Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001; 9:2165–74CrossRef Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001; 9:2165–74CrossRef
9.
Zurück zum Zitat Murakami M, Kuroda Y, Matsusue S, Okamoto Y, Nakajima T, Nishimura S, et al. Treatment results of esophageal carcinoma of clinical T3, T4M0: historical comparison between neoadjuvant chemoradiotherapy followed by surgery or definitive radiotherapy and conventional surgery. Oncol Rep 2000; 7:571–8PubMed Murakami M, Kuroda Y, Matsusue S, Okamoto Y, Nakajima T, Nishimura S, et al. Treatment results of esophageal carcinoma of clinical T3, T4M0: historical comparison between neoadjuvant chemoradiotherapy followed by surgery or definitive radiotherapy and conventional surgery. Oncol Rep 2000; 7:571–8PubMed
10.
Zurück zum Zitat Mariette C, Finzi L, Fabre S, Balon JM, Van Seuningen I, Triboulet JP. Factors predictive of complete resection of operable esophageal cancer: a prospective study. Ann Thorac Surg 2003; 75:1720–6PubMedCrossRef Mariette C, Finzi L, Fabre S, Balon JM, Van Seuningen I, Triboulet JP. Factors predictive of complete resection of operable esophageal cancer: a prospective study. Ann Thorac Surg 2003; 75:1720–6PubMedCrossRef
11.
Zurück zum Zitat Piessen G, Mariette C, Triboulet JP. Cervical and upper-third thoracic esophageal carcinoma: a single pathological entity? Ann Chir 2005; 130:86–91PubMedCrossRef Piessen G, Mariette C, Triboulet JP. Cervical and upper-third thoracic esophageal carcinoma: a single pathological entity? Ann Chir 2005; 130:86–91PubMedCrossRef
12.
Zurück zum Zitat Manshanden CG, Hulscher JB, Hovius M, Fockens P, van Lanschot JJ, Obertop H. Limited resection for carcinoma of the upper thoracic oesophagus is not a realistic option. Eur J Surg Oncol 2000; 26:561–6PubMedCrossRef Manshanden CG, Hulscher JB, Hovius M, Fockens P, van Lanschot JJ, Obertop H. Limited resection for carcinoma of the upper thoracic oesophagus is not a realistic option. Eur J Surg Oncol 2000; 26:561–6PubMedCrossRef
13.
Zurück zum Zitat Westerterp M, van Westreenen HL, Reitsma JB, Hoekstra OS, Stoker J, Fockens P, et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy-systematic review. Radiology 2005; 236:841–51PubMedCrossRef Westerterp M, van Westreenen HL, Reitsma JB, Hoekstra OS, Stoker J, Fockens P, et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy-systematic review. Radiology 2005; 236:841–51PubMedCrossRef
14.
Zurück zum Zitat Mariette C, Balon JM, Maunoury V, Taillier G, Van Seuningen I, Triboulet JP. Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma. Br J Surg 2003; 90:1367–72PubMedCrossRef Mariette C, Balon JM, Maunoury V, Taillier G, Van Seuningen I, Triboulet JP. Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma. Br J Surg 2003; 90:1367–72PubMedCrossRef
15.
Zurück zum Zitat Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. (Eds). AJCC Cancer Staging Manual, 6th ed., New York: Springer Verlag, 2002 Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. (Eds). AJCC Cancer Staging Manual, 6th ed., New York: Springer Verlag, 2002
16.
Zurück zum Zitat Mariette C, Piessen G, Lamblin A, Mirabel X, Adenis A, Triboulet JP. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. Br J Surg 2006; 93:1077–83PubMedCrossRef Mariette C, Piessen G, Lamblin A, Mirabel X, Adenis A, Triboulet JP. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. Br J Surg 2006; 93:1077–83PubMedCrossRef
17.
Zurück zum Zitat Bedenne L, Seitz JF, Milan C, Renard P, Fraisse J, Conroy T, et al. Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study. Gastroenterol Clin Biol 1998; 22:273–81PubMed Bedenne L, Seitz JF, Milan C, Renard P, Fraisse J, Conroy T, et al. Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study. Gastroenterol Clin Biol 1998; 22:273–81PubMed
18.
Zurück zum Zitat Zuccaro G Jr, Rice TW, Goldblum J, Medendorp SV, Becker M, Pimentel R, et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 1999; 94:906–12PubMedCrossRef Zuccaro G Jr, Rice TW, Goldblum J, Medendorp SV, Becker M, Pimentel R, et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 1999; 94:906–12PubMedCrossRef
19.
Zurück zum Zitat Beseth BD, Bedford R, Isacoff WH, Holmes EC, Cameron RB. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 2000; 66:827–31PubMed Beseth BD, Bedford R, Isacoff WH, Holmes EC, Cameron RB. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 2000; 66:827–31PubMed
20.
Zurück zum Zitat Brucher BL, Weber W, Bauer M, Fink U, Avril N, Stein HJ, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001; 233:300–9PubMedCrossRef Brucher BL, Weber W, Bauer M, Fink U, Avril N, Stein HJ, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001; 233:300–9PubMedCrossRef
21.
Zurück zum Zitat Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, et al. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg 2006; 243:472–8PubMedCrossRef Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, et al. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg 2006; 243:472–8PubMedCrossRef
22.
Zurück zum Zitat Reed CE, Eloubeidi MA. New techniques for staging esophageal cancer. Surg Clin North Am. 2002; 82:697–710PubMedCrossRef Reed CE, Eloubeidi MA. New techniques for staging esophageal cancer. Surg Clin North Am. 2002; 82:697–710PubMedCrossRef
23.
Zurück zum Zitat Woronoff AS, Mercier M, Gignoux M, Triboulet JP, Chaillard G, Bosset JF. Prognostic factors in operable epidermoid esophageal cancers. Gastroenterol Clin Biol 1998; 22:168–74PubMed Woronoff AS, Mercier M, Gignoux M, Triboulet JP, Chaillard G, Bosset JF. Prognostic factors in operable epidermoid esophageal cancers. Gastroenterol Clin Biol 1998; 22:168–74PubMed
24.
Zurück zum Zitat Elias D, Lasser P, Hatchouel JM, Escudier B, Spielmann M, Girinsky T, et al. A multivariate prospective study of prognostic factors in 200 operated epidermoid cancers of the esophagus. Definition of patients for whom surgical resection was of benefit. Gastroenterol Clin Biol 1993; 17:17–25PubMed Elias D, Lasser P, Hatchouel JM, Escudier B, Spielmann M, Girinsky T, et al. A multivariate prospective study of prognostic factors in 200 operated epidermoid cancers of the esophagus. Definition of patients for whom surgical resection was of benefit. Gastroenterol Clin Biol 1993; 17:17–25PubMed
25.
Zurück zum Zitat Sugimachi K, Watanabe M, Sadanaga N, Ikebe M, Mori M, Kitamura K, et al. Pre-operative estimation of complete resection for patients with oesophageal carcinoma. Surg Oncol 1994; 3:327–34PubMedCrossRef Sugimachi K, Watanabe M, Sadanaga N, Ikebe M, Mori M, Kitamura K, et al. Pre-operative estimation of complete resection for patients with oesophageal carcinoma. Surg Oncol 1994; 3:327–34PubMedCrossRef
26.
Zurück zum Zitat Picus D, Balfe DM, Koehler RE, Roper CL, Owen JW. Computed tomography in the staging of esophageal carcinoma. Radiology 1983; 146:433–8PubMed Picus D, Balfe DM, Koehler RE, Roper CL, Owen JW. Computed tomography in the staging of esophageal carcinoma. Radiology 1983; 146:433–8PubMed
27.
Zurück zum Zitat Downey RJ, Akhurst T, Ilson D, Ginsberg R, Bains MS, Gonen M, et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 2003; 21:428–32PubMedCrossRef Downey RJ, Akhurst T, Ilson D, Ginsberg R, Bains MS, Gonen M, et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 2003; 21:428–32PubMedCrossRef
28.
Zurück zum Zitat Laterza E, de Manzoni G, Guglielmi A, Rodella L, Tedesco P, Cordiano C. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg 1999; 67:1466–9PubMedCrossRef Laterza E, de Manzoni G, Guglielmi A, Rodella L, Tedesco P, Cordiano C. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg 1999; 67:1466–9PubMedCrossRef
29.
Zurück zum Zitat Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, et al. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 2004; 101:1776–85PubMedCrossRef Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, et al. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 2004; 101:1776–85PubMedCrossRef
Metadaten
Titel
Patients with Locally Advanced Esophageal Carcinoma Nonresponder to Radiochemotherapy: Who Will Benefit From Surgery?
verfasst von
Guillaume Piessen
Nicolas Briez
Jean-Pierre Triboulet
Christophe Mariette
Publikationsdatum
01.07.2007
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 7/2007
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9405-9

Weitere Artikel der Ausgabe 7/2007

Annals of Surgical Oncology 7/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.